News
More news
- New COVID-19 vaccination round for risk groups this autumn
- Mirjam Luijten appointed Professor of Human-Relevant Risk Assessment of Chemical Substances
- Chance of smog from ozone in the province of North Brabant and central parts of the Netherlands
- Wet year causes low quantities of nitrate under derogation farms
- Safe use of purified wastewater in agriculture and horticulture
- RIVM monitors situation around nuclear facilities in Iran
Featured topics
Flu and flu jab
Flu and flu vaccine
Population screening programmes
Population screening programmes
Nitrogen
Nitrogen
Climate Change and Health
Climate Change and Health
History
Our history
22-week vaccination
22-week vaccination (maternal whooping cough vaccination)
Recent publications
- Bevolkingsblootstelling aan luchtvervuiling 2022 en 2023
- Verkenning proxies voor nitraat
- Feasibility study into the addition of severe organic cation transporter 2 (OCTN2) deficiency to the newborn blood spot screening
- Practical implementation of the Social Support Act. Differences in organisation and spending of municipalities
- Protocol for Systematic Evidence Collection and Evaluation supporting health-based guidance value derivation for PFAS
- Mixture risk assessment approaches to evaluate oral exposure to PFAS
- Methodology for health-based guidance value (HBGV) derivation for PFAS (individually and in mixtures)
- Verkenning vervolg risicobeoordeling toepassing teruggewonnen cellulose - opties voor verfijnen triggerwaarden
- Bereikbaarheidsanalyse SEH’s en acute verloskunde 2025